HOME >> BIOLOGY >> NEWS
Controlling body size by regulating the number of cells

Why are elephants bigger than mice? The main reason is that mice have fewer cells. Research published in Journal of Biology this week uncovers a key pathway that controls the number of cells in an animal, thereby controlling its size.

Ernst Hafen and his colleagues from the University of Zrich used fruit flies to investigate the role of the insulin-signalling pathway and in particular a molecule called FOXO. If insulin signalling is reduced, for example by starving developing fly larvae, FOXO activity increases; this then reduces the number of cells in the developing flies, causing them to be smaller.

Mammals have similar a signalling pathway, and it has been suggested to have a role in tumour formation. Hafen's work gives us more insights into how disruption of FOXO function can lead to cancer.

The researchers used a combination of genetic techniques, over expressing FOXO in parts of the fly and analysing flies that contained no functional FOXO protein, to investigate what FOXO does. They found that flies with no functional FOXO looked normal but were more sensitive to oxidative stress, thought to be a cause of ageing. Increasing the amounts of highly active FOXO protein in the developing fly eye caused many of the eye cells to die. However, the real clue to FOXO's function came from studying the effect of removing functional FOXO protein from flies that have a reduced ability to signal downstream of insulin.

Normally, reducing insulin signalling in developing flies causes these flies to become smaller as they have fewer, smaller cells. Yet without FOXO, these flies do not suffer such a severe size reduction. This is because they have more cells than normal insulin signalling pathway mutants. These experiments suggest that FOXO plays a role in reducing the number of cells in the developing fly if insulin is not present, by inhibiting cell division.

Hafen and his co-authors write, "In this study we provide genetic
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-207-323-0323
BioMed Central
6-Aug-2003


Page: 1 2

Related biology news :

1. Controlling biomolecules with magnetic tweezers
2. Controlling the internal clock in darkness
3. Controlling cell adhesion: Researchers report first evidence of catch bonds
4. Controlling greenhouse gas carbon dioxide through carbon sequestration two-day symposium, April 2-3
5. New Gene Holds Promise For Controlling Crohns And Other Inflammatory Diseases
6. Controlling Problem Snakes: Saipan Benefits From USGS Research
7. New Discovery Offers Hope For Controlling Cholesterol, Atherosclerosis
8. Boosting Immune Response Against HIV-1 Key To Controlling Infection, Say University Of Pittsburgh Researchers
9. R-Type Channels - A New Type Of Calcium Channels Controlling Signal Transduction Between Neurons In The Brain
10. Curing Malaria, Controlling Mosquitoes Symposium Set For AAAS Meeting
11. Two Parasitic Wasps Show Promise For Controlling Pest Flies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Controlling body size regulating the number cells

(Date:7/25/2014)... a pleiotropic factor characterized by the existence of ... that confer to the protein deeply different characteristics. ... myelination occurring during development and the different phases ... degeneration, axon regrowth, remyelination and target reinnervation, Researchers ... that the soluble NRG1 upregulation observed in Schwann ...
(Date:7/25/2014)... of a molecular testing panel developed at UPMC ... initial surgery for patients with thyroid nodules and ... Cancer Institute (UPCI), partner with UPMC CancerCenter., The ... and other diagnostic testing agencies, improved the chances ... 30 percent, according to the study published this ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... biotechnology company in the emerging field of regenerative ... live webcast of a presentation to investors on ... 1:30 p.m. PDT.  The presentation will include an ... pipeline. To access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics ...
(Date:7/24/2014)... Yet, scientists are making progress in devising suitable ... approach relies on quantum dotsa kind of artificial ... A new study demonstrates that changing the coupling ... electrical impulses can help better control them. This ... as quantum information units, which would produce faster ...
(Date:7/24/2014)... 24, 2014 Research and Markets ... and Proteomics Analytical Instruments Market 2014-2018" report to ... Genomics is the study of the gene ... the structure and functions of proteomes or sets of ... technology. Genomics involves the mapping of genes and DNA ...
(Date:7/24/2014)... Three companies from the angelMD network were ... Competition. Out of 700 competition entrants, Chiron Health, Litesprite, ... round. In this round twenty teams are invited to ... mentoring from thought-leaders and medical entrepreneurs from all over ... commitment to the Livestrong vision around the Big C ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
Cached News: